Skip to main content

Drug Interactions between Konsyl Daily Fiber Therapy and MiraLAX

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

No interactions were found between Konsyl Daily Fiber Therapy and MiraLAX. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Konsyl Daily Fiber Therapy

A total of 28 drugs are known to interact with Konsyl Daily Fiber Therapy.

  • Konsyl daily fiber therapy is in the drug class laxatives.
  • Konsyl daily fiber therapy is used to treat Constipation.

MiraLAX

A total of 221 drugs are known to interact with MiraLAX.

Drug and food interactions

Moderate

polycarbophil food

Applies to: Konsyl Daily Fiber Therapy (polycarbophil)

Polycarbophil may interact with other medications if given at the same time. This can cause your other medications to become less effective. In general, all oral medications should be administered at least 2 hours before or 2 hours after dosing of polycarbophil. Take polycarbophil with a full glass (at least 8 ounces) of cool water or another liquid. Taking polycarbophil without enough liquid may cause it to swell in the throat and cause choking.

Switch to professional interaction data

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer